| Name | Title | Contact Details |
|---|---|---|
Kris Jamsa |
Chief Technology Officer | Profile |
Cornerstone Specialty Network is a company that provides value to community-based oncology practices through network aggregation, delivering value-added opportunities that support independence and long-term sustainability for community oncology practices.
Lumilife is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
QueensCare Family Clinics is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. QueensCare Family Clinics is based in Los Angeles, CA. You can find more information on QueensCare Family Clinics at www.queenscare.org
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
At Healthify, we build the infrastructure to support end-to-end care coordination across our social service networks.